Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Bioxyne.
RELATED STOCKHEAD STORIES
News
Closing Bell: Cannabis stocks bounce back; Ovanti soars 275pc after hiring Zip’s ex-CFO
Health & Biotech
Bioxyne’s revenue soars 48pc after key manufacturing licences boost growth
Health & Biotech
Health Check: ‘Cannabis corner’ in the green with record revenues and favourable deals
News
Top 10 at 11: Investor action, board room change and solid quarterly growth are today’s news
Health & Biotech
Health Check: Experts deliver their verdict on the Healius imaging deal and it’s ‘yeah nah’
Stockhead TV
Long Shortz with Bioxyne: Cannabis pastilles in an Aussie first
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Windy day for stocks as ANZ, Tabcorp get stung by regulators
News
ASX Lunch Wrap: Jumbo, Inghams, Accent sink, ending ASX winning streak
News
ASX Lunch Wrap: Shares on track for 10th straight gain, First Lithium soars, Megaport sinks 20pc
Stockhead TV
Break it Down: Bioxyne goes gummy gaga in Australian first
News
Top 10 at 11: Gold, gas, money and THC gummies are today’s happy news
Health & Biotech
Bioxyne sweetens the pot as Australia’s first manufacturer of pharmaceutical cannabis gummies
News
Market Highlights: Wall Street halts winning streak, but Netflix and gold price hit record highs
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
News
Rise and Shine: Everything you need to know before the ASX opens
News
